ReviewTexas Heart Institute journal1994
Mechanisms of restenosis.
Review in Texas Heart Institute journal, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review.Cardiovascular toxicology · 2024Pooled it
- Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.The Cochrane database of systematic reviews · 2013Pooled it
- Effect of the intravascular low energy laser illumination during percutaneous coronary intervention on the inflammatory process in vascular wall.Lasers in medical science · 2013Article
- Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation.Gene therapy · 1999Article
- Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements.Gene therapy · 1999Article
- Dynamics of Vascular Remodeling: An Overview and Bibliography.Journal of thrombosis and thrombolysis · 1996Article
- Myocardial revascularization. Historical considerations.Texas Heart Institute journal · 1994Article
- Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.Seminars in dialysisReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Restenosis after percutaneous transluminal coronary angioplasty remains a problem, which suggests that we still do not fully understand its mechanisms. We review here the current understanding of the cell biology of restenosis, including clinical correlation (risk factors), randomized clinical trials, human histology, animal models, and in vitro studies.
Indexed as
Identifiers
8180514PMC325134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.